Los Angeles, CA – June 12, 2025 - The Terasaki Institute for Biomedical Innovation (TIBI) is proud to be featured in Cell Biomaterials by Cell Press, highlighting key moments and insights from our 2025 Terasaki Innovation Summit. The article captures powerful reflections from world-renowned leaders in bioengineering, regenerative medicine, AI-powered healthcare, and translational science, all united by a shared mission to advance human health through innovation.
Held in Los Angeles this past March, the summit convened experts across academia, industry, and clinical care to discuss emerging technologies, bold new therapies, and the future of interdisciplinary biomedical research. From breakthroughs in nanomedicine and precision diagnostics to cutting-edge cell therapies and AI-driven tools, the event underscored the importance of collaboration in translating visionary science into impactful healthcare solutions.
Featured speakers included Dr. Chad Mirkin, who highlighted advances in nanomedicine for cancer and infectious diseases, and Dr. Stephen Quake, who shared how single-cell atlases are transforming precision medicine. Dr. Dino Di Carlo discussed the need for functional cell data to enhance AI applications, while Dr. Mark Skylar-Scott presented new approaches for scaling tissue engineering to organ-level solutions.
Dr. Aydogan Ozcan introduced AI-powered imaging tools for virtual tissue staining, and Dr. Tejal Desai detailed implantable devices for treating type 1 diabetes. Dipanjan Nag, spoke on the role of intellectual property in accelerating healthcare innovation, and Dave Whelan moderated a panel on fostering academia-industry partnerships. The summit was hosted by Dr. Ali Khademhosseini, who emphasized building ecosystems where science and patient care converge.
We’re honored to be recognized by Cell Press and extend our gratitude to the extraordinary speakers and partners who made this year’s summit a dynamic and inspiring success.
Read the full article here: https://lnkd.in/gQMsMHg4